SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (58)8/2/2006 11:57:43 AM
From: Mike McFarland  Read Replies (1) of 210
 
Chapter 7: Interviews With Industry Experts
Michael Foley, Ph.D., Vice President, Chemistry, Infinity Pharmaceuticals
drugandmarket.com

There is a brochure here: Second url, the pdf:

google.com

Far too pricey for me, but several topics that I have
repeatedly tripped on are in there: Natural products
chemistry, DOS, Click Chemistry. And several companies
in addition to Infinity that keep coming up, including
accl, amri, arql, Evotec, EXEL, PCOP, Vernalis.
Syrrx and Tripos too.

This is the sort of thing that a biotech fund manager
kets to piss his days away reading. Jealous.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News